Alemtuzumab versus interferon beta-1a in early multiple sclerosis
Clinical Trials Report
- 59 Downloads
KeywordsMultiple Sclerosis Chronic Lymphocytic Leukemia Alemtuzumab Natalizumab Immune Thrombocytopenic Purpura
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
- 1.Goodin DS, Cohen BA, O’Connor P, et al.: Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008, 71:766–773.PubMedCrossRefGoogle Scholar
© Current Medicine Group, LLC 2009